" Sun Life Financial (TSX:SLF) partners with CloudMD (TSXV:DOC)

Sun Life (SLF) has partnered with CloudMD (DOC) to add its Mental Health Coach solution to group benefits plans.
Theratechnologies - CEO, Paul Lévesque.

" Theratechnologies (TSX:TH) receives 2021 ADRIQ Innovation Award

Theratechnologies (TH) has taken home a 2021 ADRIQ Innovation Award in the Life Sciences category.
Cloud DX - Connected Health Kit.

" Cloud DX (TSXV:CDX) announces $170,000 in non-dilutive funding

Cloud DX (CDX) has been granted C$170,000 to commercialize its Vitaliti and Connected Health innovations.
Advanced Proteome - Dr. Saumyadip Nemu

" Advanced Proteome Therapeutics (TSXV:APC) expands its operations

Advanced Proteome Therapeutics (APC) U.S. subsidiary, Advanced Proteome Therapeutics (APTI) is expanding operations with a new hire and additional lab space.

" Quipt (TSXV: QIPT) announces LOI to acquire leader in comprehensive respiratory care

Quipt Home Medical (QIPT) has executed a non-binding LOI to acquire a private respiratory care company servicing seven states throughout the U.S.

" FluroTech’s (TSXV:TEST) pandemic response platform ready for clinical trials

FluroTech (TEST) is reporting that its point of access test system for SARS-CoV-2 detection is fully functional.

" Loon Energy (TSXV:LNE.H) enters LOI for reverse takeover with Optimind Pharma

Loon Energy Corporation (LNE.H) and Optimind Pharma Inc. have entered a LOI for a reverse takeover transaction.
The Market Herald Video

" Rakovina Therapeutics (TSXV:RKV) partners with St. Baldrick’s Foundation

Rakovina (RKV) is partnering with St. Baldrick’s Foundation to develop treatments for childhood bone cancer.

" ScreenPro (CSE:SCRN) closes acquisition of Concierge Medical Consultants

ScreenPro (SCRN) has completed its acquisition of Concierge Medical Consultants from Datametrex AI (DM).
Levitee Labs - CEO, Pouya Farmand.

" Levitee Labs (CSE:LVT) to acquire specialty addiction pharmacies in B.C.

Levitee Labs (LVT) has signed an LOI to acquire a chain of specialty addiction pharmacies in B.C.

" NervGen (TSXV:NGEN) presents phase 1 clinical trial data for NVG-291

NervGen Pharma Corp. (NGEN), a clinical-stage biotech company, has provided updates on its Phase 1 program with NVG-291.
Cloud DX - Vitaliti monitor.

" Cloud DX’s (TSXV:CDX) AcuScreen facilitates tuberculosis triage

Cloud DX’s (CDX) AcuScreen has shown promising results to screen for tuberculosis in Mozambique.

" ScreenPro (CSE:SCRN) to acquire Concierge Medical Consultants

ScreenPro (SCRN) has entered into an LOI to acquire Concierge Medical Consultants from Datametrex AI (DM).
Resverlogix - CEO, Donald McCaffrey.

" Resverlogix (TSX:RVX) in discussions for COVID-19 clinical studies in Morocco

Resverlogix (RVX) is in discussions to launch Phase 2 COVID-19 clinical studies with Apabetalone in Morocco.

" Marvel Biosciences (TSXV:MRVL) developing novel non-hallucinogenic neuroplastic promoting compounds

Marvel Biosciences (MRVL) has launched a program to identify and develop agents that promote neuroplasticity without the risks or side effects of psychedelics.
Small Pharma - CEO, Peter Rands.

" Small Pharma (TSXV:DMT) granted European patent

Small Pharma (DMT) has been granted a European patent, strengthening its ketamine-based patent portfolio.
Theratechnologies - Chief Medical Officer and Senior Vice President Dr. Christian Marsolais

" Theratechnologies (TSX:TH) confirms effectiveness of PDCs against vasculogenic mimicry

Theratechnologies (TH) reports its investigational peptide-drug conjugates (PDCs) are effective in inhibiting vasculogenic mimicry (VM) in ovarian and breast cancer models.
Small Pharma - Chief Medical and Scientific Officer, Carol Routledge.

" Small Pharma (TSXV:DMT) granted fast-track designation for DMT-assisted therapy

Small Pharma (DMT) has been granted fast-track designation in the U.K. for DMT-assisted therapy for major depressive disorder.
Field Trip Health - President, Hannan Fleiman.

" Field Trip Health (TSX:FTRP) announces three new therapy centers

Field Trip Health (FTRP) is announcing new psychedelic-assisted therapy centers in Seattle, Vancouver and Fredericton.